Immunoembolization is an exciting new area which involves the delivery of systemic immunotherapy agents such as granulocyte-macrophage colony-stimulating factor (GM-CSF) into the arteries supplying the HCC [219]. This evidence concerns the gene CSF2 and hepatocellular carcinoma.